TY - JOUR
T1 - Infective endocarditis in people who inject drugs
T2 - A scoping review of clinical guidelines
AU - Selitsky, Lea
AU - Racha, Savitha
AU - Rastegar, Darius
AU - Olsen, Yngvild
N1 - Publisher Copyright:
© 2022 Society of Hospital Medicine.
PY - 2023/2
Y1 - 2023/2
N2 - Background: The incidence of infective endocarditis (IE) among people who inject drugs (PWID) is rising worldwide. Multiple clinical guidelines differ on the management of this condition, and few guidelines comment on treatment for primary substance use disorder (SUD). A comprehensive comparison of these guidelines is lacking. Objectives: To perform a critical review identifying key differences in clinical guideline recommendations for treating IE among PWID, focusing on the inclusion of recommendations for SUD treatment and the presence of stigmatizing language. Eligibility Criteria: Recently published, English-language, society-developed clinical guidelines for the treatment of IE among PWID. Sources of Evidence: PubMed, Google Scholar, and CINAHL Plus databases. Charting Methods: In line with Arksey and O'Malley's framework, a scoping review was adapted using Joanna Briggs Institute and PRISMA-ScR guidelines. Two reviewers independently performed database searches for clinical guidelines published between 2007 and 2020 that commented on the management of IE among PWID. Results: Ten clinical guidelines were included in the final analysis. Treatment recommendations varied with some societies proposing nonstandard care due to concern for return to drug use. Three guidelines include reference to addiction treatment. Only one guideline specifies the use of opioid agonist therapy for treating opioid use disorder and identifies the benefits of an addiction specialist consultation. Acute withdrawal management is not mentioned in any guideline. All guidelines utilized stigmatizing language to describe PWID. Conclusions: Most guidelines do not address SUD treatment, despite its effectiveness in reducing adverse health outcomes. Future guidelines should address SUD treatment using patient-first language.
AB - Background: The incidence of infective endocarditis (IE) among people who inject drugs (PWID) is rising worldwide. Multiple clinical guidelines differ on the management of this condition, and few guidelines comment on treatment for primary substance use disorder (SUD). A comprehensive comparison of these guidelines is lacking. Objectives: To perform a critical review identifying key differences in clinical guideline recommendations for treating IE among PWID, focusing on the inclusion of recommendations for SUD treatment and the presence of stigmatizing language. Eligibility Criteria: Recently published, English-language, society-developed clinical guidelines for the treatment of IE among PWID. Sources of Evidence: PubMed, Google Scholar, and CINAHL Plus databases. Charting Methods: In line with Arksey and O'Malley's framework, a scoping review was adapted using Joanna Briggs Institute and PRISMA-ScR guidelines. Two reviewers independently performed database searches for clinical guidelines published between 2007 and 2020 that commented on the management of IE among PWID. Results: Ten clinical guidelines were included in the final analysis. Treatment recommendations varied with some societies proposing nonstandard care due to concern for return to drug use. Three guidelines include reference to addiction treatment. Only one guideline specifies the use of opioid agonist therapy for treating opioid use disorder and identifies the benefits of an addiction specialist consultation. Acute withdrawal management is not mentioned in any guideline. All guidelines utilized stigmatizing language to describe PWID. Conclusions: Most guidelines do not address SUD treatment, despite its effectiveness in reducing adverse health outcomes. Future guidelines should address SUD treatment using patient-first language.
UR - http://www.scopus.com/inward/record.url?scp=85141622649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141622649&partnerID=8YFLogxK
U2 - 10.1002/jhm.12996
DO - 10.1002/jhm.12996
M3 - Review article
C2 - 36349984
AN - SCOPUS:85141622649
SN - 1553-5592
VL - 18
SP - 169
EP - 176
JO - Journal of Hospital Medicine
JF - Journal of Hospital Medicine
IS - 2
ER -